Join the 'Virazole' group to help and get support from people like you. How it works
Virazole Blog
| Tweet |
Tailored Hepatitis C Therapy May Cut Treatment Time in Half
Posted 14 Sep 2011 by Drugs.com
WEDNESDAY, Sept. 14 – Patients infected with hepatitis C virus who have an early favorable response to a new three-drug regimen can be cured of the disease in half the normal time, a new study says. In the multinational study, researchers showed that tailoring patients' treatment regimen to their response to the drugs, which is known as response-guided therapy, enabled many patients to cut treatment time in half and still achieve the same cure rates. The paper was published Sept. 15 in the New England Journal of Medicine. "Patients treated with this regimen who clear virus from their blood by 4 weeks of therapy and who remain virus negative after 12 weeks of therapy can shorten total treatment time from 48 to 24 weeks and have an excellent chance of hepatitis C virus cure," said the study's lead author, Dr. Kenneth E. Sherman, Gould Professor of Medicine and director of the digestive ... Read more
Related support groups: Hepatitis C, Incivek, Pegasys, Ribavirin, Victrelis, PegIntron, Copegus, Telaprevir, Rebetol, Peginterferon Alfa-2B, Virazole, Rebetron, Ribasphere, Boceprevir, Peginterferon Alfa-2A